Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
A hands-on comparison between the two shows how the latest image models differ on price, speed, and creative control.
Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results